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reduction of bleeding as compared to GPI & >70% RR reduction as
compared to UFH. Access site bleeding was similarly the least i.e.
0.79% with Bivalirudin as compared to 1.62% with GPI & 2.98%
with UFH alone. A single episode of stent thrombosis was noticed
in the heparin + GPI arm. All cause mortality was noticed in 2.8%
of heparin+ GPI group only as compared to none in either UFH
alone or the Bivalirudin group. No ischemia driven TLR was
noticed in any of the groups. Economic impact analysis revealed
Bivalirudin to be equally effective although at an added cost.
Conclusion: Bivalirudin causes lesser bleeding as compared to
UFH +/- GPI in the setting of PCI with similar clinical efficacy. Use
of Bivalirudin resulted in significantly lower bleeding as well as
the requirement of blood transfusions with a lower mortality
though at an added procurement cost.
The influence of long stent length on clinical and
angiographic outcome in patients with coronary
artery disease
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Background: Long lesions account for approximately 20% of PCI.
Recently DES are widely used in routine clinical practice for more
complex and long lesions. Stent length has been considered an
important predictor of adverse events after PCI. Even with the DES
use, treatment of long lesions presents challenges and limited
data are available on the long-term efficacy and safety of long DES
in this complex lesion subset.
Objective: To prospectively evaluate the influence of long stent
length on clinical and angiographic outcome, in patients with
coronary artery disease (CAD).
Methods: The present study included 660 consecutive patients
who underwent long segment elective coronary artery stenting.
The patients were divided into 3 groups depending upon the stent
length 24-28mm, 29-32mm and >32 mm. The Clinical follow-up
was performed for all patients at 1, 3, 6, 9 and 12 months, and
every 3 months thereafter. Study endpoints were major adverse
cardiac events including cardiac death, myocardial infarction,
repeat revascularization and stent thrombosis.
Results: Total 660 patients were enrolled of which 71% weremales,
risk factors hypertension and diabetes being the commonest 56%
and38% respectivelyThenumber ofpatients in the 3 groupsof stent
length 24-28mm, 29-32mm and >32 mmwere 32%, 30%, 38%.Mean
stent length was 26.4±2.7mm, 30.1±2.6 mm and 40±6.3mm. Clini-
cally drivenTLRwas1.6%andonecardiacdeathwas reporteddue to
subacute stent thrombosis. Clinical outcomes were compared be-
tween diabetic (DM) (n¼ 252) and non-DM patients (n¼ 408). Base-
line characteristicswere similar in the two groups. Stent length and
MACE were found to be higher in diabetic subgroup.
Conclusion: The use of >32mm DES for treatment of long stent
lesions had a overall low MACE rate except in the subgroups of
overlapping long DES and DM patients.
Trans (left) radial coronary interventions e A
single centre experience
Col. R. Girish, Col. S. Garg
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Background: Transradial approach is increasingly used for coro-
nary diagnosis & interventions and has gone through the trans-
formation from a highly specialized, technically demanding
procedure available to a selected population to a simplified
alternative to transfemoral route. The right radial approach is the
one commonly used in most centres.
Methods: This short study in Central Command Hospital, Luck-
now was designed to study the feasibility of using the left radial
approach. The only contraindication was the absence of perfusion
from the ulnar artery when the radial artery was occluded by
pressure as assessed by Allen's test.
The left radial artery was cannulated using 21G, 4 cm long
introducer needle, 0.021” x 16” spring guide wire and 6 11cm x
0.021” 6 F sheath following which a spasmolytic cocktail
compsed of Nicorandil 8 mg & Enoxaparin 20 mg for angiogra-
phies & 60 mg for angioplasties, was administered.4F, 5F & 6F
Judkins Left (JL) & Right(JR) , Amplatz Left(AL-2) and 5F Tiger &
Kimny coronary diagnostic catheters with Terumo guide wire
0.035” x 260 cm were used for coronary angiography.5F& 6F JL,
JR, EBU & AL-2 guide catheters were used for coronary
angioplasties.
Results: Of 1123 patients who underwent procedures through the
left radial approach, from April 2013 to June 2014, the numbers of
males were 793 (70%) and females were 332 (30%). The mean age
was 55 years (range: 30-80 years). The mean weight was 70 kg
(range: 50 to 90 kg). The mean fluoroscopic time was 5.5 min
(range: 1-10 min) and the mean procedure time 15 min (range 10-
30 min). The procedure was successful in 1110(99%) patients. The
remaining 13(1%) unsuccesful procedures due to spasm, were
completed after changing over to right transfemoral route in 10
(1%) and left transulnar in 3(0.1%) patients. Coronary artery dis-
ease was detected in 832 (74%) patients. Coronary angioplasties
were carried out in 304 (27%) patients; single vessel procedures in
229 (20%), multivessel procedures in 75(7%); primary angio-
plasties in 15 (1%); chronic total occlusion interventions in
6(0.5%); left main istenting in 1(0.05%); rota stenting in 1(0.05%);
saphenous vein graft stenting in 2(0.1%) & renal stenting in
01(0.05%) patients.
Transcoronary pacing was carried out whenever needed during
interventions. Post procedure compression was done using roller
gauze & elastoplast. No significant loops or tortuosities were
encountered. There were no bleeding complications even in cases
where Gp IIb / IIIA inhibitors were used. Asymptomatic left radial
artery thrombosis was documented during predischarge Doppler
in 11 (1%) patients with subsequent recanalization within 3
months in 8 patients.
Conclusions: Routine left radial approach is a safe, convenient
&patient friendly alternative to right transradial and transfemoral
approach in patients undergoing coronary angiographies &
interventions.
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Background: The transradial approach to cardiac catheterization
has many advantages over the transfemoral approach and is
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increasingly being used for both diagnostic coronary angiography
and percutaneous coronary intervention. Radial artery occlusion
is a complication of transradial catheterization that can lead to
permanent occlusion of the radial artery. Estimated incidence in
different studies is around 10%. Once radial artery is occluded, it
cannot be used for future catheterization and become inappro-
priate for bypass graft. Hand ischaemia due to radial artery oc-
clusion requiring medical or surgical attention is reported in 0.2%
of patients. So in our study we tried to assess incidence of radial
artery occlusion following transradial catheterization & also tried
to assess effect of placebo vs postprocedural intra arterial nitro-
glycerine on incidence of radial artery occlusion on day 1.
Methods: In our study we selected 430 patients who underwent
transradial catheterization. 226 patients were given post-
procedural 200ug nitroglycerine before removal of radial sheath
while 204 patient were given placebo. Next day all patients were
evaluated with duplex ultrasound for radial artery antegrade flow.
Results: Out of 430 patients, 144 had no antegrade flow in radial
artery. Incidence of radial artery occlusion on day 1was 33% in our
study.
Out of 226 patients who were given intra arterial nitroglycerine,
45 had no antegrade flow in radial artery.
While in placebo group out of 204 patients, 99 developed radial
artery occlusion. So, radial artery patency rate was significantly
higher (p value <0.001) in nitroglycerine group as compared to
placebo group.
Conclusion: Radial artery occlusion is usually a clinically silent
event due to good collateral from ulnar artery but Radial artery
occlusion cannot be ignored as it is having several disadvantages
for patient, cardiologist as well as for surgeon. Radial artery oc-
clusion rate can be minimized by this very simple intervention in
form of post procedural 200ug nitroglycerine before removal of
radial sheath.
Our experience with drug eluting balloons for
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G. Sengottuvelu, I. Sathyamurthy, Abraham Ommen,
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Background: Role of drug eluting balloons for in-stent re-stenosis
(ISR) and small vessel coronary artery disease was shown to be
promising. DEB alone was shown to be superior to drug eluting
stent in ISR and to BMS plus DEB in small vessel disease.
Aims: To present the immediate and short term outcome of our
experience with DEB.
Methods: We collected the data of all consecutive patients who
have undergone DEB at our centre in the last nine months. We
present their demographic profile, indications, procedural out-
comes and short term clinical outcomes.
Results: Nine patients (6 male & 3 female) underwent percuta-
neous interventionwith DEB at our centre in the last ninemonths.
Seven of them were for small vessel disease with a mean refer-
ence vessel diameter of 1.93±2.8 mm, and in two patient it was for
drug eluting stent ISR. Pre dilatation was done for all lesions
before DEB and cutting balloon was used for opening the ISR
before DEB. In all the seven patients with small vessel disease,
2mm balloons were used to dilate at or below the nominal pres-
sure and there good distal flow in all of them. Four of them were
paclitaxel eluting and four were sirolimus eluting balloons. As all
patients received a DES in another vessel they were all maintained
on oral dual anti-platelet therapy till the last follow up. The mean
follow up period was 148±63 days till which time there was no
major adverse cardiovascular events.
Conclusion: Drug eluting balloon in our experience has excellent
procedural and short term outcome for small vessel PCI and ISR.
Prevalence of CYP2C19 gene polymorphism in
patients with acute coronary syndrome
undergoing PCI
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Background: Clopidogrel is metabolized in liver to its active form
by cytochrome P450 enzyme. The production of this enzyme is
controlled by several genes including CYP2C19 gene. Two single
nucleotide polymorphisms (SNPS) in the CYP2C12 gene have
found to be significantly associated with clopidogrel metabolism.
Methods: We studied 100 consecutive patients undergoing PCI for
acute coronary syndrome for single nucleotide polymorphism in
CYP2C19 gene, by GAAP e X METHOD.
Results: Out of 100 patients, 22 patients (22%) were poor metab-
oliser, and 34 patients (34%) were intermediate metaboliser, and
44% were normal metaboliser. Nearly 22% of patients who are
poor metaboliser were given newer agents like ticagrelor or pra-
sugrel and in intermediate metabolisers, the dose of clopidogrel
was increased to 150 mg OD.
Conclusion: CYP2C19 gene polymorphism is common in south
Indian population and poor metabolisers are given newer agents
to prevent stent thrombosis and recurrent cardiac events.
Safety and efficacy of the Frontrunner XP Catheter
for recanalization of chronic total occlusion of the
femoropopliteal arteries
Ranjan Shetty, G. Vivek
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Objective: The purpose of this study was to examine the safety
and efficacy of the Frontrunner XP CTO (chronic total occlusion)
catheter (Cordis Corporation) for recanalization of CTO of femo-
ropopliteal arteries.
Methods: A retrospective analysis of consecutive patients with
critical limb ischemia (CLI) who underwent femoropopliteal an-
gioplasty for TransAtlantic Inter-Society Consensus (TASC) class
D lesions between 2009 and 2011 was performed. Twenty-two
patients were enrolled with a mean age of 58.9 ± 11.5 years. Pa-
tients were enrolled with totally occluded arteries (mean occlu-
sion length, 18.0 ± 10.1 cm) that were treated with the Frontrunner
XP CTO catheter. All lesions were complex (TASC D) and 86.4% of
the lesions weremildly calcified. A Frontrunner catheter was used
to treat 22 CTOs after guidewire failure.
Results: Twenty-two of the 33 cases (66.7%) had failed previous
attempts of percutaneous intervention with conventional guide-
wire. The Frontrunner catheter was used to treat 22 CTOs after
guidewire failure. The Frontrunner catheter successfully facili-
tated the placement of a guidewire into the distal true lumen in 21
cases (95.5%). Thrombolysis in Myocardial Infarction 3 flow was
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